Method of providing pirfenidone therapy to a patient
US7696236B2 · kind B2 · utility
26Cited by
3References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 21, 2009 |
| Grant date | Apr 13, 2010 |
| Priority date | — |
| Expiry date | Apr 21, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61J2205/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods for decreasing adverse events associated with pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone) therapy. The invention discloses an optimized dose escalation scheme that results in the patient having increased tolerance to adverse events associated with the administration of pirfenidone. The invention also discloses a starter pack that may be used in conjunction with the dose escalation scheme.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.